Shares of AngioDynamics Inc. (NASDAQ:ANGO) traded down 1.2% on Tuesday . The company traded as low as $16.51 and last traded at $16.56, with a volume of 67,421 shares traded. The stock had previously closed at $16.76.

Separately, Zacks Investment Research raised shares of AngioDynamics from a “sell” rating to a “hold” rating in a research report on Thursday, August 11th. Five research analysts have rated the stock with a hold rating and one has assigned a buy rating to the company’s stock. The company has a consensus rating of “Hold” and a consensus target price of $14.10.

The company’s market cap is $608.98 million. The company has a 50-day moving average price of $15.81 and a 200 day moving average price of $12.97.

AngioDynamics (NASDAQ:ANGO) last posted its quarterly earnings results on Wednesday, July 13th. The company reported $0.19 earnings per share for the quarter, topping analysts’ consensus estimates of $0.16 by $0.03. The business had revenue of $93.40 million for the quarter, compared to analyst estimates of $88.64 million. During the same quarter in the previous year, the firm posted $0.14 earnings per share. The business’s revenue was up 2.8% compared to the same quarter last year. On average, equities research analysts anticipate that AngioDynamics Inc. will post $0.63 EPS for the current year.

In other AngioDynamics news, major shareholder Avista Capital Partners Gp, Ll sold 2,241,000 shares of the business’s stock in a transaction dated Friday, August 5th. The shares were sold at an average price of $14.62, for a total value of $32,763,420.00. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director David F. Burgstahler sold 2,250,000 shares of the business’s stock in a transaction dated Friday, August 5th. The shares were sold at an average price of $14.62, for a total transaction of $32,895,000.00. Following the completion of the transaction, the director now owns 23,988 shares in the company, valued at $350,704.56. The disclosure for this sale can be found here.

AngioDynamics, Inc designs, manufactures and sells a range of medical, surgical and diagnostic devices used by professional healthcare providers for vascular access, for the treatment of peripheral vascular disease, and for use in oncology and surgical settings. The Company’s devices are used in minimally invasive, image-guided procedures.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.